BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26402500)

  • 1. No Association between Intravenous Contrast Material Exposure and Adverse Clinical Outcome: Are Prevention Protocols Effective?
    Gramberg MC; Penne EL
    Radiology; 2015 Oct; 277(1):306. PubMed ID: 26402500
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous contrast material and acute kidney injury: a need for caution.
    Mirrakhimov AE; Mirrakhimov EM
    Radiology; 2015 Jun; 275(3):931. PubMed ID: 25997138
    [No Abstract]   [Full Text] [Related]  

  • 3. Response.
    McDonald RJ; McDonald JS; Carter RE; Hartman RP; Katzberg RW; Kallmes DF; Williamson EE
    Radiology; 2015 Oct; 277(1):306-7. PubMed ID: 26668855
    [No Abstract]   [Full Text] [Related]  

  • 4. Response.
    McDonald RJ; McDonald JS; Carter RE; Hartman RP; Katzberg RW; Kallmes DF; Williamson EE
    Radiology; 2015 Jun; 275(3):931-2. PubMed ID: 26199958
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality.
    McDonald RJ; McDonald JS; Carter RE; Hartman RP; Katzberg RW; Kallmes DF; Williamson EE
    Radiology; 2014 Dec; 273(3):714-25. PubMed ID: 25203000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidences of acute kidney injury, dialysis, and graft loss following intravenous administration of low-osmolality iodinated contrast in patients with kidney transplants.
    Fananapazir G; Troppmann C; Corwin MT; Nikpour AM; Naderi S; Lamba R
    Abdom Radiol (NY); 2016 Nov; 41(11):2182-2186. PubMed ID: 27377897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of iodixanol and iohexol in patients undergoing intravenous pyelography: a prospective controlled study.
    Chuang FR; Chen TC; Wang IK; Chuang CH; Chang HW; Ting-Yu Chiou T; Cheng YF; Lee WC; Chen WC; Yang KD; Lee CH
    Ren Fail; 2009; 31(3):181-8. PubMed ID: 19288321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-induced nephropathy in outpatients with preexisting renal impairment: a comparison between intravenous iohexol and iodixanol.
    Cernigliaro JG; Haley WE; Adolphson DP; Jepperson MA; Crook JE; Thomas CS; Parker AS
    Clin Imaging; 2016; 40(5):902-6. PubMed ID: 27183138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and nephrologic tolerance of iopromide and iotrolan in computed tomography.
    Langer M; Langer R; Zwicker C; Speck U; Jänicke UA; Felix R
    Invest Radiol; 1991 Nov; 26 Suppl 1():S83-5; discussion S88-91. PubMed ID: 1808156
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the nephrotoxicity between ioversol and iohexol.
    Hayami S; Ishigooka M; Suzuki Y; Hashimoto T; Nakada T; Mitobe K
    Int Urol Nephrol; 1996; 28(5):615-9. PubMed ID: 9061418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal effects of nonionic contrast media after intravenous cardiac, and lumbar aortic injections.
    Jakobsen JA; Kolbenstvedt AN; Levorstad K; Berg KJ; Enge I
    Invest Radiol; 1990 Sep; 25 Suppl 1():S135-6. PubMed ID: 2283233
    [No Abstract]   [Full Text] [Related]  

  • 12. Is the use of intravenous contrast material truly safe in patients with impaired renal function?
    Cohen MD
    Radiology; 2009 May; 251(2):613; author reply 613-4. PubMed ID: 19401587
    [No Abstract]   [Full Text] [Related]  

  • 13. The rabbit renal toxicity test: a sensitive in vivo test for the nephrotoxicity of contrast agents.
    Pettersson G; Towart R; Grant D; Thyberg K; Golman K
    Acad Radiol; 2002 May; 9 Suppl 1():S62-4. PubMed ID: 12019897
    [No Abstract]   [Full Text] [Related]  

  • 14. Rate of major adverse renal or cardiac events with iohexol compared to other low osmolar contrast media during interventional cardiovascular procedures.
    McCullough PA; Todoran TM; Brilakis ES; Ryan MP; Gunnarsson C
    Catheter Cardiovasc Interv; 2019 Feb; 93(2):E90-E97. PubMed ID: 30280476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Within-hospital and 30-day outcomes in 107,994 patients undergoing invasive coronary angiography with different low-osmolar iodinated contrast media.
    LaBounty TM; Shah M; Raman SV; Lin FY; Berman DS; Min JK
    Am J Cardiol; 2012 Jun; 109(11):1594-9. PubMed ID: 22440116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal effects of bicarbonate versus saline infusion for iso- and lowosmolar contrast media in rats.
    Ladwig M; Flemming B; Seeliger E; Sargsyan L; Persson PB
    Invest Radiol; 2011 Nov; 46(11):672-7. PubMed ID: 21623210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective injection of iopentol, iohexol and metrizoate into the left coronary artery of the dog. Induction of ventricular fibrillation and decrease of aortic pressure.
    Almén T; Bååth L
    Acta Radiol Suppl; 1987; 370():65-8. PubMed ID: 2980315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late allergy-like reactions following vascular administration of radiography contrast media.
    Pedersen SH; Svaland MG; Reiss AL; Andrew E
    Acta Radiol; 1998 Jul; 39(4):344-8. PubMed ID: 9685816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonionic contrast media in pediatric CT. A comparative study of intravenous use of iopentol and iohexol.
    Wiklund LM; Brolin I; Sjöholm K
    Acta Radiol; 1994 Mar; 35(2):186-90. PubMed ID: 8172749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure to low- vs iso-osmolar contrast agents reduces NADPH-dependent reactive oxygen species generation in a cellular model of renal injury.
    Netti GS; Prattichizzo C; Montemurno E; Simone S; Cafiero C; Rascio F; Stallone G; Ranieri E; Grandaliano G; Gesualdo L
    Free Radic Biol Med; 2014 Mar; 68():35-42. PubMed ID: 24300339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.